Skip to content
Trial Eligibility
Menu

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

NCT04711915

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Major Depressive Disorder
  • Depression

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
21 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Yale University
Last updated on ClinicalTrials.gov
November 18, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Connecticut · 1

  • Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine · West Haven, CT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.